Literature DB >> 18061675

S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.

Karen L Atkins1, Julia D Burman, Emily S Chamberlain, Jessica E Cooper, Bernard Poutrel, Stefan Bagby, A Toby A Jenkins, Edward J Feil, Jean M H van den Elsen.   

Abstract

The evasion of the host immune response is central to the pathogenicity of Staphylococcus aureus, and is facilitated by the ability of the cell wall-associated protein A (SpA) to bind immunoglobulin G Fc fragments, thereby impeding phacocytosis and classical pathway complement fixation. SpA also acts as a B-cell superantigen through interactions with the heavy-chain variable part of Fab fragments, and sequesters immunoglobulins by forming large insoluble immune complexes with human IgG. Here we show that the formation of insoluble immune complexes is mediated by the binding of (VH3+) Fab fragments in addition to Fc, and that SpA forms soluble complexes with IgG Fc fragments. We compared these results with those for Sbi, a second staphylococcal immunoglobulin-binding protein, and note that this protein requires only the Fc fragment for precipitation with human IgG. Homology models of immunoglobulin-binding domains of SpA and Sbi in complex with Fc reveal the molecular basis of the Fab-independent formation of insoluble complexes by Sbi. Finally, we compared the sequences of the spa and sbi genes from human strains to those infecting a range of animal hosts to determine whether Sbi and SpA have acquired specificity for host IgG. We note remarkable sequence conservation within the IgG-binding domains of these genes, consistent with a lack of host specificity. The Fab-independent binding of IgG by Sbi could have significant clinical implications. The use of SpA in immunoadsorption therapy can cause severe side-effects, thought to be mediated by Fc gamma R recognition and complement fixation. The formation of insoluble immune complexes with Sbi occurs only via Fc binding and free Fc regions are unlikely to be available for Fc gamma R recognition and complement fixation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061675     DOI: 10.1016/j.molimm.2007.10.021

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  48 in total

Review 1.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

2.  Synthetic effects of secG and secY2 mutations on exoproteome biogenesis in Staphylococcus aureus.

Authors:  Mark J J B Sibbald; Theresa Winter; Magdalena M van der Kooi-Pol; G Buist; E Tsompanidou; Tjibbe Bosma; Tina Schäfer; Knut Ohlsen; Michael Hecker; Haike Antelmann; Susanne Engelmann; Jan Maarten van Dijl
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

3.  Regional profiling for determination of genotype diversity of mastitis-specific Staphylococcus aureus lineage in Canada by use of clumping factor A, pulsed-field gel electrophoresis, and spa typing.

Authors:  Kamaleldin B Said; Johanne Ismail; Jennifer Campbell; Michael R Mulvey; Anne-Marie Bourgault; Serge Messier; Xin Zhao
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

4.  The good side of inflammation: Staphylococcus aureus proteins SpA and Sbi contribute to proper abscess formation and wound healing during skin and soft tissue infections.

Authors:  Cintia D Gonzalez; Camila Ledo; Eliana Cela; Inés Stella; Chunliang Xu; Diego S Ojeda; Paul S Frenette; Marisa I Gómez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-07-09       Impact factor: 5.187

Review 5.  Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.

Authors:  Isaac P Thomsen; George Y Liu
Journal:  JCI Insight       Date:  2018-03-08

Review 6.  Immunopathogenesis of Staphylococcus aureus pulmonary infection.

Authors:  Dane Parker; Alice Prince
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

7.  Epicutaneous model of community-acquired Staphylococcus aureus skin infections.

Authors:  Ranjani Prabhakara; Oded Foreman; Roberto De Pascalis; Gloria M Lee; Roger D Plaut; Stanley Y Kim; Scott Stibitz; Karen L Elkins; Tod J Merkel
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

8.  A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule.

Authors:  Svetlana Chabelskaya; Olivier Gaillot; Brice Felden
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

9.  Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP.

Authors:  Misty L Kuhn; Prachi Prachi; George Minasov; Ludmilla Shuvalova; Jiapeng Ruan; Ievgeniia Dubrovska; James Winsor; Monica Giraldi; Massimiliano Biagini; Sabrina Liberatori; Silvana Savino; Fabio Bagnoli; Wayne F Anderson; Guido Grandi
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

Review 10.  Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.

Authors:  Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Journal:  J Mol Med (Berl)       Date:  2010-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.